bpc-157 tendon healing human clinical trial Frontiers Stable Gastric Pentadecapeptide BPC 157

The most common side effects, nausea, constipation, and fatigue, are most prominent during this transition

Expected timeline: Week 1-4: Inflammation reduction, potential nerve symptom improvement Week 4-8: Progressive healing, reduced radicular symptoms Week 8-12: Structural improvements developing, continued symptom reduction Week 12-16: Consolidation of gains, assessment for continued protocol Important notes: Disc herniations vary enormously in severity

Crecente-Campo, J., Borrajo, E., Vidal, A

INCI naming and regulatory considerations For EU CPNP notification and most international cosmetic-regulatory frameworks, INCI names must appear in the finished-product ingredient list: GHK-Cu : Copper Tripeptide-1 AHK-Cu : Custom INCI required